Having been battered over the past month, the All Ordinaries Index (ASX: XAO) is up a slender 0.49% in a year, but this soon-to-be ASX All Ords stock has left those gains in the dust.
The surging company in question is cold spray solutions provider Titomic Ltd (ASX: TTT).
And I say "soon to be" ASX All Ords stock because Titomic won't officially join the All Ords until 24 March.
That's when the rebalances from the S&P Dow Jones Indices March quarterly review take effect. And with Titomic shares going atomic over the past year, its surging market cap has earned it a place among some of the larger ASX companies.
And this could offer up more tailwinds for the stock, as it means index tracking funds meant to mimic the All Ords will now be buying shares.
So, just how much have Titomic shares delivered to an investor who bought $8,000 worth of shares last year?
Let's dig into the maths.
One year ago, you could have picked up Titomic shares for 3.3 cents apiece.
Meaning your $8,000 investment would have netted you 242,424 shares (exclusive of brokerage fees).
At Friday's close, the ASX All Ords stock was trading for 24.0 cents per share.
That means the $8,000 worth of shares purchased just 12 months ago is now worth an eye-watering $58,182. Or a gain of 627.3%.
Boom!
Titomic released its half-year results on 28 February.
For the six months to 31 December, the ASX All Ords stock reported a 61% year on year increase in customer sales revenue to $3.7 million.
The half-year also saw Titomic successfully complete a $30 million capital raise to help fund its United States expansion and global growth ambitions.
As for that expansion, the half-year saw the company secure Huntsville, in the US state of Alabama, as the foundation for its operations in the world's largest defence and aerospace market.
Commenting on the half-year performance for the ASX All Ords stock, Titomic managing director Jim Simpson said:
2025 marks a transformation for Titomic. We are pivoting toward a service-oriented business model, recurring revenue streams, and deepening our direct sales capabilities. Our cold spray solutions are not just groundbreaking, they are reshaping the landscape of industrial manufacturing and repair.
Looking ahead, Simpson said Titomic "is not just keeping pace with industry demand, it is shaping the future of metal additive manufacturing".
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。